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Chemoprevention is based upon the use of natural or synthetic products to eliminate or minimize the 
development of cancer1. Many cancers are thought to occur due to processes such as oxidative stress and 
lipid peroxidation causing DNA damage. Chemopreventive compounds may prevent such damage from 
occurring. Chalcones belong to the flavonoid based group of compounds and have been reported to 
possess cancer chemopreventive properties2,3. In this study, we investigated the ability of novel synthetic 
chalcones to act as chemopreventive agents. The aim was to assess the ability of the chalcones to switch on 
the transcription factor Nrf2 thus inducing many cell defence genes. This was achieved using the AREc32 
reporter cell line that contains the luciferase gene linked to the antioxidant response element (ARE), which 
is a sequence found within the promoters of cell defence genes to which the Nrf2 transcription factor 
binds4.  
The luciferase reporter AREc32 cell line was exposed to varying concentrations of synthetic chalcones to 
determine a suitable non-toxic concentration to use (MTT assay). The AREc32 cells were then exposed to 
this non-toxic concentration of chalcones for 24 h after which the amount of luciferase activity (Nrf2 
activity) was quantified. Of the 30 chalcones tested, 12 chalcones were found to activate the luciferase 
reporter gene by 2-fold or more (relative to untreated control) with the greatest induction being 16-fold.  
Further investigations are now in progress to delineate the common structural features of the chalcones 
that give the greatest induction in addition to the ability of these chalcones to prevent cellular cytotoxicity.  
Acknowledgements: The authors wish to thank KR and RA (De Montfort University Leicester) for the kind provision of 
the synthetic chlacones, Professor Roland Wolf (University of Dundee) for use of the AREc32 cell line and the Iraqi 
Government for funding HJ.  
Keywords: Chemoprevention; Cancer; Chalcone; Nrf2  
References:  
1. Steward W.P. & Brown K., 2013. Cancer chemoprevention: a rapidly evolving field. British Journal of Cancer, 109, 1–
7.  
2. Suwito H. et al., 2014. Chalcones: Synthesis, structure diversity and pharmacological aspects. Journal of Chemical 
and Pharmaceutical Research, 6 (5), 1076-1088.  
3. Zhou B. and Xing C., 2015. Diverse Molecular Targets for Chalcones with Varied Bioactivities. Medicinal Chemistry, 
5, 388–404.  
4. Wang X.J. et al., 2006. Generation of a stable antioxidant response element-driven reporter gene cell line and its 
use to show redox-dependent activation of Nrf2 by cancer chemotherapeutic agents. Cancer Research, 66, 10983-
10994.  
 
